Successful treatment of EGFR-mutated non-small cell lung cancer with reduced-dose gefitinib: A case report

Author：

E-ISSN： 1792-1015|10|1|386-388

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.10, Iss.1, 2015-01, pp. : 386-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1599-1600

Spandidos Publications

Access to resources Recommend Favorite

Effects of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in EGFR-mutated non-small cell lung cancer

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 2066-2072

Spandidos Publications

Access to resources Recommend Favorite

High efficacy of gefitinib in the treatment of EGFR mutationpositive advanced nonsmall cell lung adenocarcinoma: A case report

Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. : 1320-1322

Spandidos Publications

Access to resources Recommend Favorite

Successful treatment of non-small cell lung tumor with 15 lesions by CyberKnife radiosurgery: A case report

Experimental and Therapeutic Medicine, Vol. 6, Iss. 3, 2013-01 ,pp. : 808-810

Spandidos Publications

Access to resources Recommend Favorite

The Role of Irreversible EGFR Inhibitors in the Treatment of Non-Small Cell Lung Cancer: Overcoming Resistance to Reversible EGFR Inhibitors

By Belani Chandra P.

Cancer Investigation, Vol. 28, Iss. 4, 2010-04 ,pp. : 413-423

Informa Healthcare

Access to resources Recommend Favorite